News from delmar pharmaceuticals A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Feb 24, 2015, 08:00 ET

DelMar Pharmaceuticals to Present Clinical and Preclinical Abstracts for VAL-083 at the American Association of Cancer Research (AACR) Annual Meeting in April 2015

 DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), today announced that it will be presenting three abstracts based on...

Feb 12, 2015, 08:00 ET

DelMar Pharmaceuticals Announces December 31, 2014 Financial Results and Provides Corporate Update

 DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company") today announced the filing of its financial statements for the six...

Feb 11, 2015, 08:13 ET

DelMar Pharmaceuticals Appoints Lynda Cranston, BScN, MScN, ICD.D, to the Board of Directors

 DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), today announced that it has appointed Lynda Cranston, BScN, MScN,...

Feb 10, 2015, 09:35 ET

DelMar Pharmaceuticals Completes Offer to Exchange Common Stock for Outstanding Warrants

 DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), today announced that it has completed...

Jan 13, 2015, 08:00 ET

DelMar Pharmaceuticals Receives Notice of Allowance for Third US Patent for VAL-083

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar", "the Company") today announced that the U.S. Patent and Trademark Office (USPTO) has issued a...

Jan 12, 2015, 08:00 ET

DelMar Pharmaceuticals Provides Update on VAL-083 Clinical Trial and Outlines Corporate Objectives for 2015

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar", "the Company) provided an update on the Company's ongoing Phase I/II clinical trial with...

Jan 08, 2015, 08:00 ET

DelMar Pharmaceuticals Commences Offer to Exchange Common Stock for Outstanding Warrants

 DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company", "we" or "our") today announced that it has commenced an offer to...

Jan 07, 2015, 08:00 ET

DelMar Pharmaceuticals to Present at Biotech Showcase™ 2015

 DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar", the "Company") announced today that Jeffrey Bacha, DelMar's president & CEO, will be...

Dec 02, 2014, 08:00 ET

DelMar Pharmaceuticals Joins OTCQX

 DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and "DelMar Pharma"), a clinical stage drug development company focused on the...

Nov 17, 2014, 08:00 ET
DelMar Pharmacokinetic Summary

DelMar Pharmaceuticals' Promising New Data Support the Potential of VAL-083 to Meet Significant Unmet Medical Needs in the Treatment of Glioblastoma Multiforme

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced the presentation of new data supporting the...

Nov 14, 2014, 11:45 ET

DelMar Pharmaceuticals Presents Preclinical Data Supporting VAL-083 as a Potential New Treatment in Glioblastoma at the Society of Neuro-Oncology Annual Meeting

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced the presentation of an abstract entitled, In vivo...

Nov 10, 2014, 08:00 ET

DelMar Pharmaceuticals Announces September 30, 2014 Results and Provides Corporate Update

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the company") today announced the filing of September 30, 2014 quarterly financial...

Nov 06, 2014, 08:00 ET

DelMar Pharmaceuticals Invited to Present New Data on VAL-083 in the Treatment of Glioblastoma Multiforme at the Society for NeuroOncology Annual Meeting

- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced that the Company has been invited to present three...

Oct 09, 2014, 08:44 ET

VAL-083 Demonstrates Promise as a Potential Treatment for Non-small Cell Lung Cancer

 DelMar Pharmaceuticals, Inc., (OTCQB: DMPI), a clinical-stage oncology company, today announced the presentation of promising new data...

Oct 06, 2014, 11:47 ET

DelMar Pharmaceuticals Announces Presentations at Upcoming Scientific Meetings

DelMar Pharmaceuticals, Inc., (OTCQB: DMPI), a clinical-stage oncology company, today announced that the company has been invited to present new...

Sep 04, 2014, 08:00 ET

DelMar Pharmaceuticals to Present at the SeeThruEquity Fall Microcap Investor Conference

 DelMar Pharmaceuticals, Inc., (OTCQB: DMPI), a clinical-stage oncology company, will be featured as a presenting company at the SeeThruEquity...

Sep 03, 2014, 08:00 ET

DelMar Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent for VAL-083

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced that the United States Patent and Trademark Office (USPTO) has issued a...

Aug 29, 2014, 08:00 ET

DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the Company") today announced the filing of June 30, 2014 fiscal year-end financial...

Aug 27, 2014, 14:57 ET

DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference

 DelMar Pharmaceuticals, Inc., (OTCQB: DMPI), developer of advanced cancer therapeutics, will be featured as a presenting company at the 16th...

Aug 19, 2014, 08:00 ET

DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the company") announced today a protocol amendment to allow for expanded dosing in its...